reference/33674196

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33674196

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	756
issn	1462-8902 1463-1326
issueIdentifier	8
pageRange	748-756
publicationName	Diabetes, Obesity and Metabolism
startingPage	748
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7842d4a3c63f3eec2ded513ced2c398f
bibliographicCitation	Skrivanek Z, Gaydos BL, Chien JY, Geiger MJ, Heathman MA, Berry S, Anderson JH, Forst T, Milicevic Z, Berry D. Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD‐5). Diabetes Obesity Metabolism. 2014 May 22;16(8):748–56. doi: 10.1111/dom.12305.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a636c5a76f75fa35d65b34403c2454e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e4cd45cee63a5ab16b15b8ddbb6c6c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29b278e6e0660b4d847b9d0448928f80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93740ce1df29cd6adb55784ce66bec75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7dca9b829e59ec62210a7468cb1e3a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4748b21e67962f0b5a62a30832006a72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26d1b2b4441e16683d5a501a4c56ef2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2eca673f9a73d995341ade0d005cfb97 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d1d5f8f43618593f88742228b25c853 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91b40f5926b084dd76a7d7fa7c2f7fe4
date	2014-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/24762094 https://doi.org/10.1111/dom.12305
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22008 https://portal.issn.org/resource/ISSN/1463-1326 https://portal.issn.org/resource/ISSN/1462-8902
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD‐5)
discusses	http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0557773 http://id.nlm.nih.gov/mesh/M000600817 http://id.nlm.nih.gov/mesh/M0028922 http://id.nlm.nih.gov/mesh/M0007481 http://id.nlm.nih.gov/mesh/M0011127 http://id.nlm.nih.gov/mesh/M0013535 http://id.nlm.nih.gov/mesh/M0027213 http://id.nlm.nih.gov/mesh/M0582214 http://id.nlm.nih.gov/mesh/M0018640
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011993Q000008 http://id.nlm.nih.gov/mesh/D004763Q000031 http://id.nlm.nih.gov/mesh/D007141Q000008 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D007004Q000008 http://id.nlm.nih.gov/mesh/D008687Q000627 http://id.nlm.nih.gov/mesh/D019440Q000008 http://id.nlm.nih.gov/mesh/D006943Q000517 http://id.nlm.nih.gov/mesh/D018027Q000819
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D007004Q000009 http://id.nlm.nih.gov/mesh/D019440Q000627 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D003924Q000097 http://id.nlm.nih.gov/mesh/D003924Q000150 http://id.nlm.nih.gov/mesh/D015444 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000067757 http://id.nlm.nih.gov/mesh/D003131Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D019440Q000009 http://id.nlm.nih.gov/mesh/D004763Q000008 http://id.nlm.nih.gov/mesh/D007141Q000627 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D050177Q000188 http://id.nlm.nih.gov/mesh/D004038 http://id.nlm.nih.gov/mesh/D003927 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D007141Q000009 http://id.nlm.nih.gov/mesh/D007279 http://id.nlm.nih.gov/mesh/D003924Q000628 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011993Q000009 http://id.nlm.nih.gov/mesh/D011993Q000627 http://id.nlm.nih.gov/mesh/D004763Q000627 http://id.nlm.nih.gov/mesh/D004763Q000009 http://id.nlm.nih.gov/mesh/D004359Q000009 http://id.nlm.nih.gov/mesh/D050177Q000628 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D050177Q000150
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4369359 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_33045cbeee04a3e57791bf0177468bcf http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73352

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2740

Total number of triples: 88.